Overview
Paul Markowski is a Hematologist Oncology specialist and a Hospital Medicine provider in Summit, New Jersey. Dr. Markowski is rated as an Experienced provider by MediFind in the treatment of Chronic B-Cell Leukemia (CBCL). His top areas of expertise are Thrombocytopenia, Lung Adenocarcinoma, Squamous Cell Lung Carcinoma, ALK-Positive Non-Small Cell Lung Cancer, and Bone Marrow Aspiration. Dr. Markowski is currently accepting new patients.
His clinical research consists of co-authoring 5 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
99 Beauvoir Ave, Summit, NJ 07902
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Northwell Health Center For Advanced Medicine, RJ Zuckerberg Cancer Center
The Chronic Lymphocytic Leukemia (CLL) Research and Treatment Program has become a landmark for CLL patients worldwide. Dr. Kanti Rai has been involved in diagnosing and treating CLL for almost 40 years and the staging system that bears his name came out of his early breakthrough research. His particular areas of interest are: natural history of CLL, improving prognostic features of this disease and developing newer strategies of therapy which are hypothesis-driven. Dr. Rai is an active member of the International Workshop on CLL (iwCLL) and Dr. Keating s Global CLL Foundation. He is an active member of the American Society of Clinical Oncology (ASCO), American Association for Cancer Research (AACR) and the American Society of Hematology (ASH). In 2006, Dr. Rai served as the President of ASH. He was the recipient of ASCO s David Karnofsky Memorial Award in 2012. In 2013, Dr. Rai was honored with the iwCLL David Galton award. In 2014 he was presented with ASH s Wallace H. Coulter Lifetime Achievement Award. Dr. Rai is the Joel Finkelstein Cancer Foundation Professor of Medicine, and Professor of Molecular Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell School of Medicine and Professor of Medicine at the Feinstein Institute for Medical Research, Manhasset, NY. Dr. Rai is rated as a Distinguished provider by MediFind in the treatment of Chronic B-Cell Leukemia (CBCL). His top areas of expertise are Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), Leukemia, and Richter Syndrome.
Weill Medical College Of Cornell
John Allan is a Hematologist Oncology specialist and an Oncologist in New York, New York. Dr. Allan has been practicing medicine for over 16 years and is rated as an Elite provider by MediFind in the treatment of Chronic B-Cell Leukemia (CBCL). His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Richter Syndrome, Bone Marrow Aspiration, and Splenectomy.
Icahn School Of Medicine At Mount Sinai
Adam Kittai is a Hematologist and a Hematologist Oncology provider in New York, New York. Dr. Kittai is rated as a Distinguished provider by MediFind in the treatment of Chronic B-Cell Leukemia (CBCL). His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Richter Syndrome, Small Lymphocytic Lymphoma (SLL), and Bone Marrow Aspiration. Dr. Kittai is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- ThrombocytopeniaDr. Markowski isDistinguished. Learn about Thrombocytopenia.
- Advanced
- ALK-Positive Non-Small Cell Lung CancerDr. Markowski isAdvanced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- B-Cell LymphomaDr. Markowski isAdvanced. Learn about B-Cell Lymphoma.
- Iron Deficiency AnemiaDr. Markowski isAdvanced. Learn about Iron Deficiency Anemia.
- Lung AdenocarcinomaDr. Markowski isAdvanced. Learn about Lung Adenocarcinoma.
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Pleuropulmonary BlastomaDr. Markowski isAdvanced. Learn about Pleuropulmonary Blastoma.
- Experienced
- Acute Mountain SicknessDr. Markowski isExperienced. Learn about Acute Mountain Sickness.
- AnemiaDr. Markowski isExperienced. Learn about Anemia.
- AngiosarcomaDr. Markowski isExperienced. Learn about Angiosarcoma.
- Bone Marrow AspirationDr. Markowski isExperienced. Learn about Bone Marrow Aspiration.
- Breast CancerDr. Markowski isExperienced. Learn about Breast Cancer.
- Castleman DiseaseDr. Markowski isExperienced. Learn about Castleman Disease.